** Shares of Beauty Health Company SKIN.O down 1.5% at
$7.4
** Skin treatment devices maker retracts fiscal year 2023
adjusted gross margin forecast due to Q2 margin headwinds
carrying into H2
** Separately, co appoints Michael Monahan as chief
financial officer, effective Aug. 10
** Monahan succeeds Liyuan Woo who will remain as advisor
until Sept. 1, 2023 to help with transition
** Posts Q2 net sales of $117.5 mln vs estimates of $116.09
mln - Refinitiv
** Posts Q2 EPS of 3 cents/shr vs. loss of 6 cents/share
reported year ago
** Re-affirms 2023 net sales on the strength of continued
demand for Hydrafacial and strong trends in China
** Also, reiterates long-term 2025 financial forecast
** Seven of 12 brokerages rate the stock "buy" or higher, 4
"hold"; their median PT is $15.00
** Including sessions moves, stock down 19.40% YTD
(Reporting By Akshita Toshniwal in Bengaluru)
((Akshita.Toshniwal@thomsonreuters.com))